# OnCo record folfox-family (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/folfox-family/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "folfox-family" ;
  schema:name "FOLFOX, FOLFIRI, FOLFIRINOX and CAPOX"@en ;
  schema:alternateName "FOLFOX"@en, "mFOLFOX6"@en, "FOLFIRI"@en, "FOLFOXIRI"@en, "FOLFIRINOX"@en, "mFOLFIRINOX"@en, "modified FOLFIRINOX"@en, "CAPOX"@en, "XELOX"@en, "CAPEOX"@en, "NALIRIFOX"@en, "FOLFOX/CAPOX"@en, "fluoropyrimidine-based"@en ;
  schema:description "The standard chemotherapy recipes for bowel and pancreatic cancer, named from their ingredients: FOL (folinic acid) + F (5-fluorouracil) + OX (oxaliplatin), IRI (irinotecan), or both (FOLFIRINOX). CAPOX swaps the 5-FU infusion for capecitabine tablets."@en ;
  schema:url <https://onco.cc/terms/folfox-family/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/FOLFOX> ;
  schema:citation <https://en.wikipedia.org/wiki/FOLFOX> ;
  onco:related <https://onco.cc/terms/alkylating-agent/>, <https://onco.cc/terms/peripheral-neuropathy/>, <https://onco.cc/terms/total-neoadjuvant-therapy/>, <https://onco.cc/terms/chemotherapy-regimen/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/gastric/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/oxaliplatin/>, <https://onco.cc/drugs/irinotecan/>, <https://onco.cc/drugs/fluorouracil/> .